메뉴 건너뛰기




Volumn 53, Issue 1, 2011, Pages 358-362

Identifying who is at risk of drug-induced liver injury: Is human leukocyte antigen specificity the key?

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BENOXAPROFEN; BROMFENAC; DICLOFENAC; DRUG METABOLITE; FLUCLOXACILLIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IBUFENAC; IBUPROFEN; LAPATINIB; LUMIRACOXIB; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NAPROXEN; PHENYTOIN; ROFECOXIB; SULFONAMIDE; TICLOPIDINE; TROGLITAZONE; XIMELAGATRAN;

EID: 78751555902     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24094     Document Type: Article
Times cited : (11)

References (21)
  • 1
    • 0038385271 scopus 로고    scopus 로고
    • Hepatotoxicity associated with non-steroidal anti-inflammatory drugs
    • Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin Liver Dis 2003; 7: 401-413.
    • (2003) Clin Liver Dis , vol.7 , pp. 401-413
    • Teoh, N.C.1    Farrell, G.C.2
  • 2
    • 4344661128 scopus 로고    scopus 로고
    • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
    • Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004; 364: 665-674.
    • (2004) Lancet , vol.364 , pp. 665-674
    • Schnitzer, T.J.1    Burmester, G.R.2    Mysler, E.3    Hochberg, M.C.4    Doherty, M.5    Ehrsam, E.6
  • 3
    • 78751500917 scopus 로고    scopus 로고
    • Drug safety update: Lumiracoxib hepatotoxicity. Available from Accessed December 2,
    • Drug safety update: Lumiracoxib hepatotoxicity. Available from Accessed December 2, 2010.
    • (2010)
  • 4
    • 0037353404 scopus 로고    scopus 로고
    • Troglitazone-induced liver failure: a case study
    • Graham DJ, Green L, Senior JR, Nourjah P. Troglitazone-induced liver failure: a case study. Am J Med 2003; 114: 299-306.
    • (2003) Am J Med , vol.114 , pp. 299-306
    • Graham, D.J.1    Green, L.2    Senior, J.R.3    Nourjah, P.4
  • 5
    • 0022355426 scopus 로고
    • Halothane hepatitis. Detection of a constitutional susceptibility factor
    • Farrell GC, Prendergast D, Murray M. Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 1985; 313: 1300-1314.
    • (1985) N Engl J Med , vol.313 , pp. 1300-1314
    • Farrell, G.C.1    Prendergast, D.2    Murray, M.3
  • 6
    • 77955671969 scopus 로고    scopus 로고
    • Pharmacogenetics of drug-induced liver injury
    • Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. HEPATOLOGY 2010; 52: 748-761.
    • (2010) HEPATOLOGY , vol.52 , pp. 748-761
    • Russmann, S.1    Jetter, A.2    Kullak-Ublick, G.A.3
  • 7
    • 77955082302 scopus 로고    scopus 로고
    • A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
    • Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nature 2010; 42: 711-714.
    • (2010) Nature , vol.42 , pp. 711-714
    • Singer, J.B.1    Lewitzky, S.2    Leroy, E.3    Yang, F.4    Zhao, X.5    Klickstein, L.6
  • 8
    • 77952718055 scopus 로고    scopus 로고
    • Risk factors for idiosyncratic drug-induced liver injury
    • Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010; 138: 2246-2259.
    • (2010) Gastroenterology , vol.138 , pp. 2246-2259
    • Chalasani, N.1    Björnsson, E.2
  • 9
    • 0028274260 scopus 로고
    • Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis
    • Berson A, Fréneaux E, Larrey D, Lepage V, Douay C, Mallet C, et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20: 336-342.
    • (1994) J Hepatol , vol.20 , pp. 336-342
    • Berson, A.1    Fréneaux, E.2    Larrey, D.3    Lepage, V.4    Douay, C.5    Mallet, C.6
  • 10
    • 0003963036 scopus 로고    scopus 로고
    • Schiff's Diseases of the Liver
    • 10. Philadelphia: Lippincott Williams & Wilkins, Drug induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC
    • Chitturi S, Farrell GC. Drug induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, ed. 10. Philadelphia: Lippincott Williams & Wilkins; 2007.
    • (2007)
    • Chitturi, S.1    Farrell, G.C.2
  • 12
    • 33646024613 scopus 로고    scopus 로고
    • Hy's law: predicting serious hepatotoxicity
    • Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 2006; 15: 241-243.
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , pp. 241-243
    • Temple, R.1
  • 13
    • 40949127393 scopus 로고    scopus 로고
    • How to interpret a genome-wide association study
    • Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008; 299: 1335-1344.
    • (2008) JAMA , vol.299 , pp. 1335-1344
    • Pearson, T.A.1    Manolio, T.A.2
  • 14
    • 38949104743 scopus 로고    scopus 로고
    • Idiosyncratic drug reactions: past, present, and future
    • Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008; 21: 84-92.
    • (2008) Chem Res Toxicol , vol.21 , pp. 84-92
    • Uetrecht, J.1
  • 15
    • 61849090255 scopus 로고    scopus 로고
    • Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts
    • Kang P, Dalvie D, Smith E, Renner M. Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts. Chem Res Toxicol 2009; 22: 106-117.
    • (2009) Chem Res Toxicol , vol.22 , pp. 106-117
    • Kang, P.1    Dalvie, D.2    Smith, E.3    Renner, M.4
  • 16
    • 2342541211 scopus 로고    scopus 로고
    • Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
    • Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, et al. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. HEPATOLOGY 2004; 39: 1430-1440.
    • (2004) HEPATOLOGY , vol.39 , pp. 1430-1440
    • Aithal, G.P.1    Ramsay, L.2    Daly, A.K.3    Sonchit, N.4    Leathart, J.B.5    Alexander, G.6
  • 17
    • 2542627509 scopus 로고    scopus 로고
    • HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
    • Andrade RJ, Lucena MI, Alonso A, García-Cortes M, García-Ruiz E, Benitez R, et al. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. HEPATOLOGY 2004; 39: 1603-1612.
    • (2004) HEPATOLOGY , vol.39 , pp. 1603-1612
    • Andrade, R.J.1    Lucena, M.I.2    Alonso, A.3    García-Cortes, M.4    García-Ruiz, E.5    Benitez, R.6
  • 18
    • 78049469917 scopus 로고    scopus 로고
    • Human leucocyte antigen class II genotype in susceptibility and resistance to coamoxiclav-induced liver injury
    • Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, et al. Human leucocyte antigen class II genotype in susceptibility and resistance to coamoxiclav-induced liver injury. J Hepatol 2010; 53: 1049-1053.
    • (2010) J Hepatol , vol.53 , pp. 1049-1053
    • Donaldson, P.T.1    Daly, A.K.2    Henderson, J.3    Graham, J.4    Pirmohamed, M.5    Bernal, W.6
  • 19
    • 0017158302 scopus 로고
    • Association of HLA-A3 and HLA- B14 antigens with idiopathic haemochromatosis
    • Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA- B14 antigens with idiopathic haemochromatosis. Gut 1976; 17: 332-334.
    • (1976) Gut , vol.17 , pp. 332-334
    • Simon, M.1    Bourel, M.2    Fauchet, R.3    Genetet, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.